Roland Wilhelm Kolbeck

CIK: 0002076327

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)1 (16.7%)

Derivative conversions

Awards (A)4 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)1 (16.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ACRS

Aclaris Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

ACRS
Aclaris Therapeutics, Inc.
Aug 1, 2026
Exercise(M)
Direct
36.4K shares-
ACRS
Aclaris Therapeutics, Inc.
Aug 1, 2026
Tax Payment(F)
Direct
12.4K shares at avg. $5.20$64K
ACRS
Aclaris Therapeutics, Inc.
Feb 2, 2026
Award(A)
Restricted Stock Units
Direct
95.7K shares-
ACRS
Aclaris Therapeutics, Inc.
Feb 2, 2026
Award(A)
Employee Stock Option (Right to Buy)
Direct
334.9K shares-
ACRS
Aclaris Therapeutics, Inc.
Aug 1, 2025
Award(A)
Restricted Stock Units
Direct
145.5K shares-
ACRS
Aclaris Therapeutics, Inc.
Aug 1, 2025
Award(A)
Employee Stock Option (right to buy)
Direct
510K shares-

		Type	Shares	Price		Ownership
Aug 1, 2026	ACRS Aclaris Therapeutics, Inc.	Exercise(M)	36,375	-	$0	Direct
Aug 1, 2026	ACRS Aclaris Therapeutics, Inc.	Tax Payment(F)	12,385	$5.20	$64,402	Direct
Feb 2, 2026	ACRS Aclaris Therapeutics, Inc.	Award(A) Restricted Stock Units	95,700	-	-	Direct
Feb 2, 2026	ACRS Aclaris Therapeutics, Inc.	Award(A) Employee Stock Option (Right to Buy)	334,900	-	-	Direct
Aug 1, 2025	ACRS Aclaris Therapeutics, Inc.	Award(A) Restricted Stock Units	145,500	-	-	Direct
Aug 1, 2025	ACRS Aclaris Therapeutics, Inc.	Award(A) Employee Stock Option (right to buy)	510,000	-	-	Direct

1-6 of 6 transactions

About Kolbeck Roland Wilhelm

Kolbeck Roland Wilhelm (SEC CIK 0002076327) files insider reports with the SEC as Chief Scientific Officer of Aclaris Therapeutics, Inc. (ACRS).

Signal8 holds 4 ownership filings by Kolbeck Roland Wilhelm (1 Form 3, 3 Form 4), filed between Aug 5, 2025 and Aug 4, 2026. Those filings report 6 transactions, from Aug 1, 2025 to Aug 1, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Kolbeck Roland Wilhelm's filings is in WAYNE, PA.

Recent filings by Kolbeck Roland Wilhelm

Aug 1, 2026: Option exercise of ACRS shares (Form 4, code M).
Aug 1, 2026: Tax withholding of ACRS shares (Form 4, code F).
Feb 2, 2026: Grants or awards of ACRS derivative securities (2 lines, Form 4, code A).
Aug 1, 2025: Grants or awards of ACRS derivative securities (2 lines, Form 4, code A).

Other insiders filing for Aclaris Therapeutics, Inc. (ACRS)

SCHIFF ANDREW N, Director
Mehra Anand, Director
Molineaux Christopher P., Director
Humphries William D., Director
MILANO VINCENT, Director
GOWEN MAXINE, Director

How to read Form 4 transaction codes